SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. SECURITIES EXCHANGE ACT OF 1934 RELEASE NO. 106159 / AUGUST 19, 2026 ADMIN. PROC. FILE NO. 3-22553 - Insurance News | InsuranceNewsNet

InsuranceNewsNet — Your Industry. One Source.™

Sign in
  • Subscribe
  • About
  • Advertise
  • Contact
Home Now reading Newswires
Topics
    • Advisor News
    • Annuity Index
    • Annuity News
    • Companies
    • Earnings
    • Fiduciary
    • From the Field: Expert Insights
    • Health/Employee Benefits
    • Insurance & Financial Fraud
    • INN Magazine
    • Insiders Only
    • Life Insurance News
    • Newswires
    • Property and Casualty
    • Regulation News
    • Sponsored Articles
    • Washington Wire
    • Videos
    • ———
    • About
    • Meet our Editorial Staff
    • Advertise
    • Contact
    • Newsletters
  • Exclusives
  • NewsWires
  • Magazine
  • Newsletters
Sign in or register to be an INNsider.
  • AdvisorNews
  • Annuity News
  • Companies
  • Earnings
  • Fiduciary
  • Health/Employee Benefits
  • Insurance & Financial Fraud
  • INN Exclusives
  • INN Magazine
  • Insurtech
  • Life Insurance News
  • Newswires
  • Property and Casualty
  • Regulation News
  • Sponsored Articles
  • Video
  • Washington Wire
  • Life Insurance
  • Annuities
  • Advisor
  • Health/Benefits
  • Property & Casualty
  • Insurtech
  • About
  • Advertise
  • Contact
  • Editorial Staff

Get Social

  • Facebook
  • X
  • LinkedIn
Economic News
Newswires RSS Get our newsletter
Order Prints
September 6, 2026 Newswires
Share
Share
Post
Email

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. SECURITIES EXCHANGE ACT OF 1934 RELEASE NO. 106159 / AUGUST 19, 2026 ADMIN. PROC. FILE NO. 3-22553

States News Service

The following information was released by the Securities and Exchange Commission (SEC):

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.

SECURITIES EXCHANGE ACT OF 1934

Release No. 106159 / August 19, 2026

Admin. Proc. File No. 3-22553

In the Matter of the Application of

SHINECO, INC.

For Review of Action Taken by

THE NASDAQ STOCK MARKET LLC

OPINION OF THE COMMISSION

REGISTERED SECURITIES EXCHANGE REVIEW OF DELISTING

Applicant challenged The Nasdaq Stock Market LLC's action suspending trading in, and

then delisting, the applicant's stock. Held, application for review is dismissed.

APPEARANCES:

Jacob S. Frenkel, Gregory L. Ewing, and Brian S. Yu of Dickinson Wright PLLC for

Shineco, Inc.

Amir C. Tayrani, David Salant, and Alex Gesch of Gibson, Dunn and Crutcher LLP for

The Nasdaq Stock Market LLC.

Appeal filed: October 17, 2025

Last brief received: January 14, 2026

2

Shineco, Inc., seeks review of The Nasdaq Stock Market LLC's action suspending

trading in, and then delisting, Shineco's common stock. Because the record supports Nasdaq's

determination, we sustain Nasdaq's action and dismiss Shineco's application for review.

I. Background

Nasdaq's Rule 5101 grants Nasdaq discretionary authority to suspend or delist securities

when an "event, condition, or circumstance" makes continued listing "inadvisable or

unwarranted"even when a company's securities otherwise meet all enumerated listing

criteria.1 Nasdaq exercised that authority here based on Shineco's repeated violations of

Nasdaq's listing requirements and a finding that the company's compliance history and financial

condition made sustained future compliance unlikely despite Shineco's claims of a business

turnaround.

Shineco's compliance problems began in September 2022, when Nasdaq first notified the

company that it had violated Nasdaq's "Bid Price Rule" because the company's securities had

closed below $1 per share for 30 consecutive business days.2 Over the next three years, Nasdaq

issued five such notices to Shineco. After each of the first four, Shineco regained compliance

within the 180-day cure periods that Nasdaq's rules generally provide, including twice by

conducting reverse stock splitsa 1:10 split in February 2024 and a 1:24 split in

November 2024.3

When Shineco violated the Bid Price Rule for a fifth time in June 2025, Nasdaq staff

informed the company that it was ineligible for the standard 180-day cure period. Under the

"Excessive Split Rule"adopted in January 2025a company that has conducted a reverse

stock split within the prior year is not entitled to that cure period, and the Nasdaq staff must

initiate the process for delisting the security at issue.4 Nasdaq staff therefore notified Shineco

that its securities would be suspended and delisted.

1 Nasdaq Rule 5101.

2 See Nasdaq Rules 5550(a)(2) (requiring companies listed on the Nasdaq Capital Market

to maintain a minimum bid price of $1.00 per share), 5810(c)(3)(A) (providing that a failure to

meet the minimum bid price requirement exists if the deficiency continues for 30 consecutive

business days).

3 See Nasdaq Rule 5810(c)(3)(A) (providing issuers a 180-calendar-day grace period in

which to come back within compliance). If an issuer listed on the Nasdaq Capital Market does

not regain compliance within the initial 180-day compliance period, the rules provide the issuer

an additional 180-day cure period if certain criteria are met. Nasdaq Rule 5810(c)(3)(A)(ii).

Nasdaq applied this rule by affording Shineco an additional 180-day grace period after it failed

to regain compliance within the initial cure period.

4 Nasdaq Rule 5810(c)(3)(A)(iv) (providing that companies that effected a reverse stock

split in the past year are ineligible for the standard 180-day cure period and Nasdaq staff shall

issue a Staff Delisting Determination under Rule 5810 with respect to that security).

3

Shineco appealed the staff's decision to a Nasdaq Hearings Panel.5 In its written

submission, Shineco admitted that the Excessive Split Rule rendered it "not eligible" for an

automatic 180-day cure period but requested that the panel afford discretionary relief by granting

the company "a short exception within which to demonstrate compliance with" Nasdaq's listing

criteria.6

After holding a hearing, the panel denied Shineco's request. The panel did not

specifically invoke the Excessive Split Rule in its decision. Rather, it addressed the relief that

Shineco requested: whether to exercise discretion to grant the company additional time to cure its

deficiency. In denying Shineco's request, the panel found "no reason to believe" that allowing

the company time to conduct another reverse stock split would enable long-term compliance

with Nasdaq's listing standardsnoting that Shineco's latest deficiency was its fifth in three

years and that two previous stock splits had achieved only temporary compliance. The panel

recognized that Shineco had begun executing a transformation plan, but found "no proof" that

the new operations would allow Shineco to continue as a "functioning operating company." The

panel therefore concluded that Shineco's "dramatic pivot in business model" did not "inspire

confidence" and did not "justify yet another exception."

Shineco requested that Nasdaq's Listing and Hearing Review Council call the Hearings

Panel's decision for review, and the council did so.7 Although Shineco had previously admitted

that the Excessive Split Rule rendered the company ineligible for the automatic 180-day cure

period, the company reversed course before the council and argued that applying the rule was

impermissibly retroactivecontending that a rule adopted in January 2025 could not properly be

applied to take into consideration a reverse stock split that occurred in November 2024, before

the rule's adoption. Shineco also argued that the Hearings Panel had failed to adequately

consider the company's transformation plan.

On October 1, 2025, after full briefing from the parties, the council affirmed the Hearings

Panel's decision. The council began by finding that the Hearings Panel "had ample authority to

act based solely upon the Company's latest Bid Price Rule violation"without applying the

Excessive Split Rule. As the council explained, the Excessive Split Rule's "only practical

effect" was to eliminate an automatic 180-day cure period, leaving the question of whether the

company should have more time in which to cure in the Hearings Panel's discretion. Shineco

understood this, asking the panel only to afford the company "a short exception" to regain

compliance. The council found that, given Shineco's repeated noncompliance with the Bid Price

Rule, the Hearings Panel reasonably exercised its discretion not to grant Shineco's request.

5 The suspension and delisting were stayed pending the panel's review. See Nasdaq Rule

5815(a)(1)(B) (providing that, if an issuer timely appeals a delisting determination to a Nasdaq

hearings panel, the suspension and delisting will ordinarily be stayed pending the panel's

review).

6 See Nasdaq Rule 5815(c)(1)(A) (providing that a hearings panel may, in its discretion,

provide the issuer up to 180 days to cure its deficiency).

7 In ordering review, the council stayed the suspension pending that review.

4

The Listing Council then found that, even if the Excessive Split Rule did not applyand

Shineco was potentially eligible for an additional 180-day cure perioddelisting was

nonetheless warranted. The panel had discretion under Rule 5101 to immediately suspend

trading and proceed with delisting notwithstanding any automatic cure period. As discussed

above, Rule 5101 authorizes Nasdaq to suspend or delist securities when an "event, condition, or

circumstance" makes continued listing "inadvisable or unwarranted," even when a company's

securities otherwise "meet all enumerated criteria for" continued listing, such as being eligible

for additional time to cure a deficiency.

The council found that standard satisfied here. According to the council, Shineco's

"repeated cycles" of Bid Price Rule violations and multiple reverse stock splits that did "not

result in sustained compliance" raised significant concerns. The Listing Council recognized that

Shineco's claims about its transformation plan "may prove to be true," but expressed caution

given Shineco's history of violations and the council's findingwhich Shineco does not

disputethat the company had "misrepresented its quarterly financial position to hide continued

losses, even after it had begun executing its transformation plan." Shineco cited its revenue

figures for two previous quartersduring which, it claims, it had begun a successful

turnaroundwithout noting that its reports filed with the Commission for those quarters showed

net losses from continuing operations of over $2 million, and its most recent quarterly report

reflected a net loss from continuing operations of approximately $4 million.

Nasdaq suspended trading in Shineco's securities on October 7, 2025, and Shineco's

securities were delisted from Nasdaq on December 1, 2025. Shineco subsequently filed this

appeal challenging the Listing Council's decision and sought an interim stay of Nasdaq's actions

while the Commission reviewed Shineco's appeal. The Commission denied Shineco's stay

request because, among other things, the company failed to show a likelihood of success or raise

a serious legal question on the merits.8 We now turn to the merits of Shineco's appeal.

II. Analysis

We review Nasdaq's action under Exchange Act Section 19(f), which requires us to

conduct an independent review of the record to determine whether (1) the specific grounds on

which Nasdaq based an action prohibiting or limiting access to its services exist in fact; (2) the

action was in accordance with Nasdaq's rules; and (3) Nasdaq's rules are, and were applied in a

manner, consistent with the Exchange Act's purposes.9

In conducting that review, we conclude that Rule 5101 provides an appropriate basis for

Nasdaq's delisting determination. Shineco argues that the Excessive Split Rule was improperly

applied to it retroactively. But we need not address that argument because, even if that rule did

8 Shineco, Inc., Exchange Act Release No. 104272, 2025 WL 3303830 (Nov. 26, 2025).

9 15 U.S.C. 78s(f); see also SmartHeat Inc., Exchange Act Release No. 73555, 2014 WL

5768703, at *10 (Nov. 6, 2014) (applying Section 19(f) when reviewing Nasdaq delisting

decision). Section 19(f) also requires us to set aside Nasdaq's action if we find that the action

imposes an undue burden on competition. Id. Shineco does not argue, and we do not find, that

Nasdaq's action imposes such a burden here.

5

not apply to Shineco, the record supports Nasdaq's exercise of its Rule 5101 authority. And

Shineco does not challenge Rule 5101 as a basis for Nasdaq's decision or contend that Nasdaq

misapplied the rule's standards. Shineco's arguments about Nasdaq's discretion instead go to

process: that the Hearings Panel reached its decision too quickly and inadequately considered its

transformation plan. We address and reject those arguments below.

A. The specific grounds exist in fact, and Nasdaq's action was in accordance with its

rules.

The record establishes the facts on which Nasdaq based its decision. And Shineco does

not dispute them. Those facts in turn amply establish that Nasdaq's action accorded with

Rule 5101. That rule authorizes Nasdaq to act when an "event, condition, or circumstance"

makes continued listing "inadvisable or unwarranted"even when a company otherwise meets

all enumerated criteria. That was the case here.

Shineco violated the Bid Price Rule five times between September 2022 and June 2025,

including two instancesin February and November 2024in which Shineco conducted reverse

stock splits to cure its deficiencies, only for its securities to fall below $1 per share again within

months. These circumstances established a pattern of Shineco's, repeatedly and over an

extended period, not sustaining compliance with a fundamental listing standard. That

compliance history was also combined with a transformation plan that, at the time of the

delisting decision, was undermined by the company's own conduct, as the Listing Council

foundand Shineco does not disputethat the company misrepresented its quarterly financial

position to hide continued losses, with its own quarterly reports showing net losses from

continuing operations of over $2 million, and its most recent quarterly report reflecting a net loss

of approximately $4 million from continuing operations.10 Taken together, these

"circumstances" established that continued listing was "inadvisable" and "unwarranted"not

because any single factor was dispositive, but because the overall pattern demonstrated that it

was highly unlikely that Shineco could maintain compliance with listing standards.

We reject Shineco's suggestion that its prior compliancecuring its first four Bid Price

Rule deficiencies within the applicable periodsentitled it to another opportunity. Those cures

did not demonstrate a company capable of maintaining compliance. Each reverse stock split

produced only temporary relief before the bid price fell below $1 again. That pattern is itself

part of the circumstance that made continued listing inadvisable. Rule 5101 does not require

prior failure to cure before Nasdaq may act. It requires examining whether the overall events,

conditions, or circumstances made continued listing inadvisableand here, Shineco's pattern of

repeated violations and temporary cures plainly met that standard.

Because Rule 5101 independently supports Nasdaq's delisting determination, we need

not (and do not) reach Shineco's arguments about the Excessive Split Rule, including whether

10 See Shineco's Form 10-Q for the period ended March 31, 2025, available at

https://www.sec.gov/edgar/browse/?CIK=1300734 (Shineco's public EDGAR page) (last visited

August 14, 2026); Rule of Practice 323, 17 C.F.R. 201.323 (authorizing the Commission to

take official notice of any matter in its "public official records").

6

Nasdaq applied it retroactively or whether Shineco forfeited that argument by not raising it

before the Hearings Panel.

B. Nasdaq's rules are, and were applied in a manner, consistent with the Exchange

Act's purposes.

Nasdaq Rule 5101 is, and was applied in a manner, consistent with the Exchange Act's

purposes. Exchange Act Section 12(d) provides that a security registered with a national

securities exchange "may be withdrawn or stricken from listing . . . in accordance with the rules

of the exchange."11 Section 6(b)(5) requires that national securities exchanges design their rules

to "perfect the mechanism of a free and open market . . . and . . . to protect investors and the

public interest."12 Nasdaq Rule 5101's grant of discretionary authority for Nasdaq to suspend or

delist securities to maintain "public confidence in its market" and "protect investors and the

public interest" is consistent with these purposes.13

Nasdaq also applied Rule 5101 in a manner consistent with the Exchange Act's

purposes. The Commission has emphasized the importance of Nasdaq's listing standards "given

investor expectations regarding the nature of securities that have achieved an exchange listing,

and the role of an exchange in overseeing its market and assuring compliance."14 By relying on

Rule 5101 to deny Shineco another cure period before suspending and delisting the company's

securities, Nasdaq acted to preserve the integrity of Nasdaq's listing standards given the

company's financial condition and repeated inability to comply with listing requirements. This

action protected investors who rely on those standards when making investment decisions.

Shineco acknowledges Nasdaq's "broad discretion" to suspend or delist an issuer's

securities, but asserts that Nasdaq deprived Shineco of due process here by the Hearings Panel

issuing its decision less than a day after the hearing and Nasdaq giving "short shrift" to the

company's compliance plan. For this case, we will assume but not decide that the constitutional

due process standard applies to self-regulatory organizations like Nasdaq. The constitutional

requirement is satisfied when two core elements are present: notice of the grounds for the action

11 15 U.S.C. 78l(d).

12 Id. 78f(b)(5).

13 See SmartHeat, 2014 WL 5768703, at *10 (finding that Rule 5101 is consistent with the

Exchange Act's purposes).

14 E.g., Notice Of Filing Of Amend. No. 1 And Order Granting Accelerated Approval Of A

Proposed Rule Change, As Modified By Amend. No. 1, To Modify Certain Initial Listing

Liquidity Requirements, 90 Fed. Reg. 12608, 12609 and n.24 (Mar. 18, 2025); see also Tassaway,

Inc., Exchange Act Release No. 11291, 1975 WL 161326, at *2 (Mar. 13, 1975) ("[P]rospective

future investors . . . [are] entitled to assume that the securities in the system meet the system's

standards. Hence the presence in NASDAQ of non-complying securities could have a serious

deceptive effect.").

7

and a meaningful opportunity to be heard.15 That standard was satisfied here. Shineco had

notice and opportunity to be heard, and both the Hearings Panel and the Listing Council engaged

in reasoned decision makingissuing written decisions that addressed Shineco's compliance

history, its transformation plan, and each of its legal arguments.16 The speed of Nasdaq's

decision does not change this conclusion. The panel had Shineco's written submissions for

weeks before the hearing and received Shineco's presentation deck in advance of the hearing

itself. A prompt decision after a hearing at which the company had a full opportunity to be heard

is consistent with an efficient and fair proceeding.

Shineco further argues that Nasdaq violated New York law by breaching contractual

duties under the parties' listing agreement. That claim falls outside the scope of this proceeding.

Exchange Act Section 19(f) limits our review to whether Nasdaq's action was consistent with its

rules and the Exchange Act.17 Questions of state law, including breach of contract and implied

covenant claims, must be pursued in the appropriate judicial forum.18

Finally, Shineco's suggestion that Nasdaq held it to a different standard than "non-Asia

based companies" is not supported by the record. Shineco identifies no similarly situated

company that received more favorable treatment, and the record contains no basis for concluding

15 See Mathews v. Eldridge, 424 U.S. 319, 333 (1976) ("The fundamental requirement of

due process is the opportunity to be heard 'at a meaningful time and in a meaningful manner."'

(quoting Armstrong v. Manzo, 380 U.S. 545, 552 (1965))); Kendall v. Baicerzak, 650 F.3d 515,

528-29 (4th Cir. 2011) ("Procedural due process provides merely a guarantee of fair

procedurestypically notice and an opportunity to be heard." (cleaned up)).

16 See 15 U.S.C. 78f(d)(2) (providing that in determining whether to prohibit or limit a

person's access to services, an exchange must "notify such person of, and give him an

opportunity to be heard upon, the specific grounds for [the] prohibition or limitation," and an

exchange's determination to prohibit or limit a person's access to services "shall be supported by

a statement setting forth the specific grounds on which the . . . prohibition or limitation is

based").

17 See generally id. 78s(f) (providing no mechanism for reviewing a claim that SRO

action breached a member agreement or implied covenant); cf. JJFN Servs., Inc., Exchange Act

Release No. 39343, 1997 WL 722029, at *4 (Nov. 21, 1997) ("[O]ur authority to order the

NASD to include an issuer's securities is governed by Exchange Act Section 19(f), not by a

theory of promissory estoppel or quasi-contract.").

18 See Blackbook Cap., Inc., Exchange Act Release No. 97027, 2023 WL 2351451, at *4

(Mar. 2, 2023) (explaining that state law claims such as whether FINRA libeled an applicant or

breached an implied contract are "outside the scope of a Commission proceeding" (cleaned up));

Keith Patrick Sequeira, Exchange Act Release No. 85231, 2019 WL 995508, at *8 (Mar. 1,

2019) (declining to consider defamation allegations as "outside the scope of this proceeding"),

aff'd, 816 F. App'x 703 (3d Cir. 2020); Beatrice J. Feins, Exchange Act Release No. 33374,

1993 WL 538913, at *3 n.14 (Dec. 23, 1993) (explaining that "redress, if any, under

statutes must be pursued in other forums").

8

that Nasdaq's decision was motivated by anything other than Shineco's documented history of

non-compliance.

Accordingly, we dismiss Shineco's application for review. An appropriate order will

issue.19

By the Commission (Chairman ATKINS and Commissioners PEIRCE and UYEDA).

Vanessa A. Countryman

Secretary

19 We deny Shinecos request for oral argument, because our decisional process would not

be significantly aided by oral argument. See Rule of Practice 451(a), 17 C.F.R. 201.451(a).

We have considered all of the parties contentions. We have rejected or sustained them to the

extent that they are inconsistent or in accord with the views expressed in this opinion.

UNITED STATES OF AMERICA

before the

SECURITIES AND EXCHANGE COMMISSION

SECURITIES EXCHANGE ACT OF 1934

Release No. 106159 / August 19, 2026

Admin. Proc. File No. 3-22553

In the Matter of the Application of

SHINECO, INC.

For Review of Action Taken by

THE NASDAQ STOCK MARKET LLC

ORDER DISMISSING APPLICATION FOR REVIEW OF ACTION TAKEN BY

REGISTERED SECURITIES EXCHANGE

On the basis of the Commissions opinion issued this day, it is

ORDERED that the application for review filed by Shineco, Inc., is dismissed.

By the Commission.

Vanessa A. Countryman

Secretary

Older

Insurance is a promise, and State Farm has let me down | Letter

Newer

ATTORNEY GENERAL TONG URGES CONNECTICUT INSURANCE DEPARTMENT TO REJECT DOUBLE-DIGIT HEALTH INSURANCE RATE HIKE REQUESTS

Advisor News

  • Your client wants to cash out an annuity. Here’s what to consider
  • How student loan debt impacts 401(k) balances
  • The ‘sandwich generation’ faces compounded barriers to retirement savings
  • Benefit Costs Squeeze Schools, Driving Cuts, Tax Hikes And Difficult Tradeoffs
  • Why client insurance needs could change even if their life doesn’t
More Advisor News

Annuity News

  • SS&C Black Diamond Expands Annuities & Insurance Marketplace with New Insurance Capabilities and Carriers
  • Regulators urged to sharply limit hypothetical data in annuity illustrations
  • Your client wants to cash out an annuity. Here’s what to consider
  • Oklahoma Insurance Dept. helps Oklahomans recover unclaimed life insurance benefits
  • Bitcoin gains ground in retirement market with Equitable annuity option
More Annuity News

Health/Employee Benefits News

  • New York Life Enhances Survivorship Variable Universal Life with Guaranteed Death Benefit Option
  • SS&C Black Diamond Expands Annuities & Insurance Marketplace with New Insurance Capabilities and Carriers
  • NEW GAO REPORT: TAXPAYERS BANKROLLED OBAMACARE HEALTH INSURANCE PLANS COVERING ELECTIVE ABORTIONS FOR 4.4 MILLION INDIVIDUALS IN 2026
  • Trump wants your vote before he takes your healthcare away Opinion | Trump wants your vote before he takes your healthcare away
  • HYDE AMENDMENT VIOLATIONS AND TRANSPARENCY FAILURES REVEALEDNEW GAO REPORT: TAXPAYERS BANKROLLED OBAMACARE HEALTH INSURANCE PLANS COVERING ELECTIVE ABORTIONS FOR 4.4 MILLION INDIVIDUALS IN 2026
Sponsor
More Health/Employee Benefits News

Life Insurance News

  • New York Life Enhances Survivorship Variable Universal Life with Guaranteed Death Benefit Option
  • SS&C Black Diamond Expands Annuities & Insurance Marketplace with New Insurance Capabilities and Carriers
  • Oklahoma Insurance Dept. helps Oklahomans recover unclaimed life insurance benefits
  • DE-RESERVIFICATION, NOT DE-DOLLARIZATION
  • Better Business Bureau scam alert: Beware of life insurance impostors targeting older adults
Sponsor
More Life Insurance News

NEWS INSIDE

  • Companies
  • Earnings
  • Economic News
  • INN Magazine
  • Insurtech News
  • Newswires Feed
  • Regulation News
  • Washington Wire
  • Videos

FEATURED OFFERS

Press Releases

  • Classic Car Insurer OpenRoad Insurance Expands to 40 U.S. States in Two Years
  • How Aspire General Turned an Early Technology Bet Into Claims Automation at Scale with Kyber
  • Adjusto launches AI-Native contents claims services powered by its technology platform
  • URL Insurance Group Celebrates 40 Years of Service, Growth, and Industry Leadership
  • MassMutual Ascend Surpasses $2 Billion in Lifetime Advisory Annuity Sales, Reflecting Continued Momentum in RIA Channel
More Press Releases > Add Your Press Release >

How to Write For InsuranceNewsNet

Find out how you can submit content for publishing on our website.
View Guidelines

Topics

  • Advisor News
  • Annuity Index
  • Annuity News
  • Companies
  • Earnings
  • Fiduciary
  • From the Field: Expert Insights
  • Health/Employee Benefits
  • Insurance & Financial Fraud
  • INN Magazine
  • Insiders Only
  • Life Insurance News
  • Newswires
  • Property and Casualty
  • Regulation News
  • Sponsored Articles
  • Washington Wire
  • Videos
  • ———
  • About
  • Meet our Editorial Staff
  • Advertise
  • Contact
  • Newsletters

Top Sections

  • AdvisorNews
  • Annuity News
  • Health/Employee Benefits News
  • InsuranceNewsNet Magazine
  • Life Insurance News
  • Property and Casualty News
  • Washington Wire

Our Company

  • About
  • Advertise
  • Contact
  • Meet our Editorial Staff
  • Magazine Subscription
  • Write for INN

Sign up for our FREE e-Newsletter!

Get breaking news, exclusive stories, and money- making insights straight into your inbox.

select Newsletter Options
Facebook Linkedin Twitter
© 2026 InsuranceNewsNet.com, Inc. All rights reserved.
  • Terms & Conditions
  • Privacy Policy
  • InsuranceNewsNet Magazine

Sign in with your Insider Pro Account

Not registered? Become an Insider Pro.